Luz Tarín‐Arzaga

Eltrombopag and high-dose dexamethasone as frontline treatment of newly diagnosed immune thrombocytopenia in adults

David Gómez‐Almaguer, Miguel Ángel Herrera-Rojas, José Carlos Jaime‐Pérez et al. · Blood · 2014 · 99 citations

Low-dose rituximab and alemtuzumab combination therapy for patients with steroid-refractory autoimmune cytopenias

David Gómez‐Almaguer, Manuel Solano-Genesta, Luz Tarín‐Arzaga et al. · Blood · 2010 · 74 citations · Full text

Danazol as first-line therapy for aplastic anemia

José Carlos Jaime‐Pérez, Perla R. Colunga‐Pedraza, Cynthia D. Gómez-Ramírez et al. · Annals of Hematology · 2011 · 70 citations

Hematological Malignancy, Bone Marrow Failure, Pharmacology +4

High response rate to low‐dose rituximab plus high‐dose dexamethasone as frontline therapy in adult patients with primary immune thrombocytopenia

David Gómez‐Almaguer, Luz Tarín‐Arzaga, Brizio Moreno‐Jaime et al. · European Journal Of Haematology · 2013 · 68 citations

Outpatient allografting using non-myeloablative conditioning: the Mexican experience

Olga Graciela Cantú‐Rodríguez, José Carlos Jaime‐Pérez, Cesar Homero Gutiérrez‐Aguirre et al. · Bone Marrow Transplantation · 2007 · 35 citations

Mexican Experience, Transplantation, Graft Survival +2